✦ LIBER ✦

103 POSTER A phase II study of enzastaurin as second- or third-line treatment of non-small cell lung cancer (NSCLC)

✍ Scribed by Y. Oh; R. Herbst; H. Burris; A. Cleverly; M. Lahn; G. Bepler

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6615 POSTER Biweekly paclitaxel as secon

✍ Vázquez-Estévez, S.; Fírvida, J.L.; Grande, C.; Barón, F.; Lázaro, M.; Salgado, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Phase II trial of gemcitabine as second

✍ Gillenwater, HH; Tynan, M; Socinski, MA 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Phase II study of ACNU as second-line tr

✍ A. S. Th. Planting; T. A. W. Splinter; A. Ardizzoni; J. Estapé; G. Giaccone; A. 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 258 KB

A phase II study of irinotecan as a thir

✍ Matsubara, Nobumichi; Maemondo, Makoto; Inoue, Akira; Ishimoto, Osamu; Watanabe, 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 321 KB

Phase II study of 4-demethoxydaunorubici

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Phase II trial of weekly docetaxel (D) i

✍ Lilenbaum, R; Schwartz, M; Siegel, L; Belette, F; Blaustein, A; Wittlin, F; Cisn 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB